These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 19401772)

  • 1. Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol.
    Cencic R; Carrier M; Galicia-Vázquez G; Bordeleau ME; Sukarieh R; Bourdeau A; Brem B; Teodoro JG; Greger H; Tremblay ML; Porco JA; Pelletier J
    PLoS One; 2009; 4(4):e5223. PubMed ID: 19401772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model.
    Bordeleau ME; Robert F; Gerard B; Lindqvist L; Chen SM; Wendel HG; Brem B; Greger H; Lowe SW; Porco JA; Pelletier J
    J Clin Invest; 2008 Jul; 118(7):2651-60. PubMed ID: 18551192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7.
    Kim S; Hwang BY; Su BN; Chai H; Mi Q; Kinghorn AD; Wild R; Swanson SM
    Anticancer Res; 2007; 27(4B):2175-83. PubMed ID: 17695501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.
    Oblinger JL; Burns SS; Huang J; Pan L; Ren Y; Shen R; Kinghorn AD; Welling DB; Chang LS
    Exp Neurol; 2018 Jan; 299(Pt B):299-307. PubMed ID: 28610844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.
    de la Parra C; Otero-Franqui E; Martinez-Montemayor M; Dharmawardhane S
    J Biol Chem; 2012 Dec; 287(50):41640-50. PubMed ID: 23095751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of the translation inhibitor silvestrol in hepatocellular cancer.
    Kogure T; Kinghorn AD; Yan I; Bolon B; Lucas DM; Grever MR; Patel T
    PLoS One; 2013; 8(9):e76136. PubMed ID: 24086701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural compound silvestrol is a potent inhibitor of Ebola virus replication.
    Biedenkopf N; Lange-Grünweller K; Schulte FW; Weißer A; Müller C; Becker D; Becker S; Hartmann RK; Grünweller A
    Antiviral Res; 2017 Jan; 137():76-81. PubMed ID: 27864075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (-) and the eIF4A-inhibitor Silvestrol.
    Müller C; Obermann W; Schulte FW; Lange-Grünweller K; Oestereich L; Elgner F; Glitscher M; Hildt E; Singh K; Wendel HG; Hartmann RK; Ziebuhr J; Grünweller A
    Antiviral Res; 2020 Mar; 175():104706. PubMed ID: 31931103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.
    Oblinger JL; Burns SS; Akhmametyeva EM; Huang J; Pan L; Ren Y; Shen R; Miles-Markley B; Moberly AC; Kinghorn AD; Welling DB; Chang LS
    Neuro Oncol; 2016 Sep; 18(9):1265-77. PubMed ID: 26951381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses.
    Müller C; Schulte FW; Lange-Grünweller K; Obermann W; Madhugiri R; Pleschka S; Ziebuhr J; Hartmann RK; Grünweller A
    Antiviral Res; 2018 Feb; 150():123-129. PubMed ID: 29258862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer.
    Wolfe AL; Singh K; Zhong Y; Drewe P; Rajasekhar VK; Sanghvi VR; Mavrakis KJ; Jiang M; Roderick JE; Van der Meulen J; Schatz JH; Rodrigo CM; Zhao C; Rondou P; de Stanchina E; Teruya-Feldstein J; Kelliher MA; Speleman F; Porco JA; Pelletier J; Rätsch G; Wendel HG
    Nature; 2014 Sep; 513(7516):65-70. PubMed ID: 25079319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Aminomethyl SAR in a novel series of flavagline-inspired eIF4A inhibitors: Effects of amine substitution on cell potency and in vitro PK properties.
    Nilewski C; Michels TD; Packard GK; Xiang AX; Sprengeler PA; Eam B; Fish S; Thompson PA; Wegerski CJ; Nevarez A; Clarine J; Sperry S; Ernst JT; Reich SH
    Bioorg Med Chem Lett; 2021 Sep; 47():128111. PubMed ID: 34353608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo.
    Lucas DM; Edwards RB; Lozanski G; West DA; Shin JD; Vargo MA; Davis ME; Rozewski DM; Johnson AJ; Su BN; Goettl VM; Heerema NA; Lin TS; Lehman A; Zhang X; Jarjoura D; Newman DJ; Byrd JC; Kinghorn AD; Grever MR
    Blood; 2009 May; 113(19):4656-66. PubMed ID: 19190247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas.
    Chang LS; Oblinger JL; Burns SS; Huang J; Anderson LW; Hollingshead MG; Shen R; Pan L; Agarwal G; Ren Y; Roberts RD; O'Keefe BR; Kinghorn AD; Collins JM
    Mol Cancer Ther; 2020 Mar; 19(3):731-741. PubMed ID: 31848295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simplified silvestrol analogues with potent cytotoxic activity.
    Hawkins BC; Lindqvist LM; Nhu D; Sharp PP; Segal D; Powell AK; Campbell M; Ryan E; Chambers JM; White JM; Rizzacasa MA; Lessene G; Huang DC; Burns CJ
    ChemMedChem; 2014 Jul; 9(7):1556-66. PubMed ID: 24677741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors.
    Liu T; Nair SJ; Lescarbeau A; Belani J; Peluso S; Conley J; Tillotson B; O'Hearn P; Smith S; Slocum K; West K; Helble J; Douglas M; Bahadoor A; Ali J; McGovern K; Fritz C; Palombella VJ; Wylie A; Castro AC; Tremblay MR
    J Med Chem; 2012 Oct; 55(20):8859-78. PubMed ID: 23025805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation.
    Rubio CA; Weisburd B; Holderfield M; Arias C; Fang E; DeRisi JL; Fanidi A
    Genome Biol; 2014; 15(10):476. PubMed ID: 25273840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silvestrol Inhibits Chikungunya Virus Replication.
    Henss L; Scholz T; Grünweller A; Schnierle BS
    Viruses; 2018 Oct; 10(11):. PubMed ID: 30380742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel triterpenoid isolated from the root bark of Ailanthus excelsa Roxb (Tree of Heaven), AECHL-1 as a potential anti-cancer agent.
    Lavhale MS; Kumar S; Mishra SH; Sitasawad SL
    PLoS One; 2009; 4(4):e5365. PubMed ID: 19399188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia.
    Alachkar H; Santhanam R; Harb JG; Lucas DM; Oaks JJ; Hickey CJ; Pan L; Kinghorn AD; Caligiuri MA; Perrotti D; Byrd JC; Garzon R; Grever MR; Marcucci G
    J Hematol Oncol; 2013 Mar; 6():21. PubMed ID: 23497456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.